Addressing therapeutic needs in veterinary health

Anivive Lifesciences Inc Founder, CEO and Chairman Dylan Balsz discussed the veterinary drug development company’s mission and how it is working to serve unmet needs in animal health, during an interview with dvm360®at the Fetch dvm360® Conference in Kansas City, Missouri.

View the video for the full statement. The following is a partial transcript:

Dylan Balsz: Specialty medicine and veterinary pharma can only get so far if the treatments aren’t affordable and broadly available. And, so, with our cancer therapy, we’ve been able to pass that on, and it’s about $2-$5 a day in cost. That’s something that our team has strived really hard for in the last 3 years to make possible and something we’ll continue to do in the future with the rest of our pipeline.